Efficacy of TCA Effect on Varicella Atrophic Scars
The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2007 by Shahid Beheshti University of Medical Sciences.
Recruitment status was: Recruiting
Recruitment status was: Recruiting
Sponsor:
Shahid Beheshti University of Medical Sciences
Information provided by:
Shahid Beheshti University of Medical Sciences
ClinicalTrials.gov Identifier:
NCT00422539
First received: January 16, 2007
Last updated: NA
Last verified: January 2007
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This study aims to determine the efficacy of 70% trichloroacetic acid on atrophic scars of varicella
| Condition | Intervention | Phase |
|---|---|---|
|
Atrophic Varicella Scar |
Drug: 70% trichloroacetic acid |
Phase 2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Evaluation of Tri Chloro Acetic Acid (TCA) Effect on Atrophic Varicella Scars |
Resource links provided by NLM:
Further study details as provided by Shahid Beheshti University of Medical Sciences:
Primary Outcome Measures:
- Objective Clearance(before and after photographies were taken)
Secondary Outcome Measures:
- Subjective Clearance(according to the patients satisfaction)
- Adverse effects(assessed by clinician as erythema, pigmentary changes, scaring)
| Estimated Enrollment: | 100 |
| Study Start Date: | March 2006 |
high concentration trichloroacetic acid peeling has been shown to be effective in treating and flattening the atrophic acne scars. According to the lack of an effective and low cost therapy for removing these relative common and nuisance lesions; We aimed to answer that whether we could achieve the same results from 70% TCA on atrophic varicella scars.
Eligibility| Ages Eligible for Study: | 15 Years to 45 Years (Child, Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- Atrophic varicella scar on face
Exclusion Criteria:
- Active varicella infection
- Active Herpetic infection
- Previous history of keloid formation
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00422539
Please refer to this study by its ClinicalTrials.gov identifier: NCT00422539
Contacts
| Contact: Behrooz Barikbin, M.D. | 98-21-22744393 ext 5 | bbarikbin@yahoo.com |
Locations
| Iran, Islamic Republic of | |
| Skin Research Center, Shohada-e Tajrish Hospital, shaheed Beheshti Medical University | Recruiting |
| Tehran, Iran, Islamic Republic of, 198994148 | |
Sponsors and Collaborators
Shahid Beheshti University of Medical Sciences
Investigators
| Study Chair: | Parviz Toossi, M.D. | Skin Research Center of Shaheed Beheshti medical University |
| Principal Investigator: | Behrooz Barikbin, M.D. | Skin Research Center of Shaheed Beheshti Medical Universty |
More Information
| ClinicalTrials.gov Identifier: | NCT00422539 History of Changes |
| Other Study ID Numbers: |
SRC-BBA-1385-6-1 |
| Study First Received: | January 16, 2007 |
| Last Updated: | January 16, 2007 |
Keywords provided by Shahid Beheshti University of Medical Sciences:
|
trichloroacetic acid varicella scar |
Additional relevant MeSH terms:
|
Chickenpox Herpes Zoster Atrophy Herpesviridae Infections |
DNA Virus Infections Virus Diseases Pathological Conditions, Anatomical |
ClinicalTrials.gov processed this record on May 22, 2017